🔎 Trials Near Me

Home › Mga Sakit sa Baga › North Carolina › Durham

Pag-aaral pangklinika para sa Mga Sakit sa Baga sa Durham, NC

Isang pag-aaral para sa Mga Sakit sa Baga ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Nagre-recruitPhase 3
  • Research Site, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05624450

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Nagre-recruitPhase 3
  • Duke Cancer Center, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06765109

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Nagre-recruitPhase 3
  • Duke Vaccine and Trials Unit, Durham
  • Duke Vaccine and Trials Unit, Durham
  • Duke University - Main Hospital and Clinics, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07013474

American Lung Association (ALA) Lung Health Cohort

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Duke University, Durham
Edad 25 hanggang 35 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04543461

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Nagre-recruitPhase 3
  • GSK Investigational Site, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06572384

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3
  • Duke Cancer Institute, Durham
  • University of North Carolina Medical Center, Chapel Hill · 10 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
  • Duke Vaccine and Trials Unit, Durham
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07730450

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Nagre-recruitPhase 2
  • NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi ang layo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06325696

Deep Functional Phenotyping of the ALA Lung Health Cohort

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Duke University, Durham
Edad 25 hanggang 35 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT06177717

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Nagre-recruitPhase 2
  • University of North Carolina, Chapel Hill · 10 mi ang layo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT04614103

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Nagre-recruit
  • Durham VA Medical Center, Durham, NC, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT02984761

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
  • Duke University Medical Center, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 16, 2026 · NCT01280994

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Nagre-recruitPhase 2
  • Duke University Hospital, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06619561

Pag-aaral para sa Mga Sakit sa Baga sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.